Bonus Issue
[MHCARE] Bonus Issue on 07-Oct-2024
Announcement Date: 25-Sep-2024
FY: 31-Dec-2024
Amount
1.0000 : 3.0000
- Ex Date07-Oct-2024
- Entitlement Date08-Oct-2024
Description
Bonus Issue of 205,570,000 New Ordinary Shares in Metro Healthcare Berhad (Metro Share(s) or Share(s)) (Bonus Share(s)) on the Basis of 1 Bonus Share for Every 3 Existing Metro Shares
About METRO HEALTHCARE BERHAD
Metro Healthcare Berhad provides health care services. The Company offers semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. Metro Healthcare serves patients in Malaysia. How to be entitled
To be entitled for any of the above, you need to purchase the shares one trading day before the ex-Date. You will not be entitled for the above if you purchase the shares on or after the ex-Date. On ex-Date, the price will be adjusted to reflect the theoretical market price of the stock after the entitlement. You can sell the shares on / after ex-Date and still be entitled to the corporate exercise. The key is to purchase the shares before ex-Date.
How to subscribe
Shareholders that fulfill the requirement above will need to fill in and submit the right subscription form to the share registrar: Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
.png)
Apps
Top Articles
1
Mercury Securities Research
3
TA Sector Research
7
8
TechnicalWatcher
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
